Leqvio under the microscope: Real-World safety study launches
NCT ID NCT06770543
First seen Jan 10, 2026 · Last updated May 17, 2026 · Updated 16 times
Summary
This study is a required safety check by Korean health authorities after Leqvio was approved. It will track 1500 adults with high cholesterol who are prescribed Leqvio in normal clinic visits. The goal is to see how safe and effective the drug is in real life, not in a controlled experiment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGYangsan, Gyeongsangnam-do, 50612, South Korea
-
Novartis Investigative Site
RECRUITINGBusan, 49241, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 04763, South Korea
-
Novartis Investigative Site
RECRUITINGTaegu, 41944, South Korea
Conditions
Explore the condition pages connected to this study.